All In Biotech

Drug Trial Radar · NCT06523101

A Study of PJ009 in Healthy Adult Volunteers

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PJ009 in Healthy Adult Volunteers

Last checked: Nov 19, 2026Latest source record: Jul 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Feb 28, 2023

Primary completion

May 15, 2023

Study completion May 15, 2023

Sponsor

Sponsor type
Industry
First posted
Jul 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main aim of this clinical trial is to assess the safety of PJ009 in healthy adult volunteers aged 18-45. The main questions it aims to answer are: * Is PJ009 safe in healthy adult? Participants will * Receive single dose of PJ009 or placebo according to weight, and then multiple doses daily for 7 days, * Stay in hospital for assessment.

Conditions

  • Short Bowel Syndrome

Interventions

  • PJ009Drug

    Six participants in each dose level will be randomized to receive a single dose and/or multiple doses of PJ009 in a double-blind fashion.

  • PlaceboDrug

    Two participants in each dose level will be randomized to receive placebo in a double-blind fashion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-related Adverse EventsTime frame: Up to 18 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Second Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.